Strumento inattivo

Altre lingue G9pharma co., LTD

Azioni

A078650

KR7078650009

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

G9pharma co., LTD Reports Earnings Results for the Full Year Ended December 31, 2023	21/03
G9pharma co., LTD Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	14/11
G9pharma co., LTD Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	14/08/23
G9pharma co., LTD Reports Earnings Results for the First Quarter Ended March 31, 2023	15/05/23
G9pharma co., LTD Reports Earnings Results for the Full Year Ended December 31, 2022	23/03/23
G9pharma co., LTD Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	14/11/22
G9pharma co., LTD Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	16/08/22
G9pharma co., LTD Reports Earnings Results for the First Quarter Ended March 31, 2022	16/05/22
G9pharma co., LTD Reports Earnings Results for the Full Year Ended December 31, 2021	22/03/22
G9pharma co., LTD cancelled the transaction announced on November 26, 2021	25/02/22
G9pharma co., LTD announced that it has received KRW 9.9999984 billion in funding from Meritz Securities Co., Ltd., Investment Arm, Cypress Partners Co., Ltd.	14/12/21
G9pharma co., LTD announced that it has received KRW 5.999999573 billion in funding from Meritz Securities Co., Ltd., Investment Arm	01/12/21
G9pharma co., LTD announced that it expects to receive KRW 1.5 billion in funding from Cypress Partners Co., Ltd.	26/11/21
G9pharma co., LTD announced that it has received KRW 9.99999775 billion in funding from Meritz Securities Co., Ltd., Investment Arm	24/11/21
G9pharma co., LTD Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	15/11/21
Mosaic Ventures, Luck & Trust Co., Ltd., Han International Co., Ltd., Hannam World and Medi Forum Co.,Ltd. completed the acquisition of 20.9% stake in Kolen Co., Ltd from Biolog Device Co., Ltd..	02/06/21
G9pharma co., LTD announced that it expects to receive KRW 17.99999925 billion in funding from Meritz Securities Co., Ltd., Investment Arm, Cypress Partners Co., Ltd.	20/05/21
Mosaic Ventures, Luck & Trust Co., Ltd., Han International Co., Ltd., Hannam World and Medi Forum Co.,Ltd. signed an agreement to acquire 20.9% stake in Kolen Co., Ltd from Biolog Device Co., Ltd. for KRW 15.5 billion.	10/05/21
G9pharma co., LTD announced that it expects to receive KRW 25.999999573 billion in funding from Meritz Securities Co., Ltd., Investment Arm	22/04/21
1EVOLUTION Marketing Research Inc. cancelled the acquisition of 99.99% stake in KOLEN PHILIPPINES INC from Kolen Co., Ltd.	13/04/21

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue G9pharma co., LTD

Azioni

A078650

KR7078650009

Altre lingue

Filtri